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Evidence is accumulating that particulate
matter (PM) air pollution is associated with
increased cardiopulmonary morbidity and
mortality [Committee of the Environmental
and Occupational Health Assembly of the
American Thoracic Society (CEOHA-ATS)
1996; Pope and Dockery 1999; Pope et al.
2002]. Although the underlying physiologic
mechanisms for these effects are still being
explored, it has been postulated that PM’s
influence could involve altered autonomic
function and inflammatory responses indi-
cated by various blood markers (Glantz 2002;
Godleski et al. 2000; Seaton et al. 1995;
Stone and Godleski 1999; Utell et al. 2002).
Epidemiologic studies have observed ele-
vated PM exposures to be associated with spe-
ciﬁc physiologic end points, including reduced
lung function (Hoek et al. 1998), increased
blood plasma viscosity (Peters et al. 1997),
reduced heart rate variability (HRV; Gold
et al. 2000; Liao et al. 1999; Pope et al. 1999),
and markers of inflammation (Ghio and
Devlin 2001; Peters et al. 2001; Salvi et al.
1999, 2000; Schwartz 2001; Tan et al. 2000).
It has also been suggested that certain groups
may be more at risk for the effects of PM expo-
sure, including the elderly (Pope 2000). In this
study, we hypothesized that altered autonomic
function and pulmonary inﬂammation play a
role in the pathogenesis of cardiopulmonary
disease related to fine particle air pollution
[aerodynamic diameter ≤ 2.5 µm (PM2.5)]. A
primary objective of this study was to further
examine PM’s inﬂuence on cardiac autonomic
function, as measured by HRV and blood
markers of inﬂammation, by studying a panel
of elderly persons who may be more suscepti-
ble or exhibit greater response to PM.
Materials and Methods
Study areas and periods. This study was con-
ducted in three Utah communities: a) a com-
munity in Salt Lake City, Utah, referred to as
Hawthorne, located 2.5 mi (4 km) southeast
of the city’s urban center; b) Lindon, located
in the Provo/Orem metropolitan area approx-
imately 40 mi (65 km) south of Salt Lake
City; and c) Bountiful, a Salt Lake City sub-
urb, located approximately 12 mi (20 km)
north of the urban center. Sources of PM in
the communities included substantial traffic
and urban-related sources, an integrated steel
mill, and local oil reﬁneries. All three commu-
nities are located along the Wasatch Front, a
relatively densely populated area running
north and south along the western front of the
Wasatch Mountains. During winter low-level
temperature inversion episodes, PM concen-
trations become elevated as local emissions are
trapped in a stagnant air mass near the valley
ﬂoor. Thus, PM pollution levels in the winter
are generally higher and have much greater
variability than during other seasons. In
Hawthorne, data were collected during the
winter of 1999/2000 and the summer of
2000. In Bountiful and Lindon, data were
collected during the winter of 2000/2001.
Panel participants. Panels of elderly resi-
dents of the three communities were recruited
to participate in 24-hr ambulatory electro-
cardiographic (ECG) monitoring and blood
tests. Potential participants were initially
recruited by directly contacting persons living
in the neighborhoods adjacent to the moni-
toring sites and asking for neighborhood
referrals. Information about the study was
given, and for those who indicated a willing-
ness to participate, an eligibility questionnaire
was completed. A total of 89 persons were ini-
tially enrolled in the study. Six persons in
Hawthorne who participated in the winter
panel also participated in the subsequent
summer panel and, for purposes of this analy-
sis, were treated as separate subjects, which
resulted in 95 subjects. Three subjects with-
drew from the study before data collection
began, and four more withdrew with only a
single day of data collection, ﬁnally resulting in
88 subjects with 250 total observations (~2.84
observations per subject). All subjects were
nonsmokers living in homes with no smokers.
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Epidemiologic studies report associations between particulate air pollution and cardiopulmonary
morbidity and mortality. Although the underlying pathophysiologic mechanisms remain unclear, it
has been hypothesized that altered autonomic function and pulmonary/systemic inﬂammation may
play a role. In this study we explored the effects of air pollution on autonomic function measured by
changes in heart rate variability (HRV) and blood markers of inﬂammation in a panel of 88 elderly
subjects from three communities along the Wasatch Front in Utah. Subjects participated in multiple
sessions of 24-hr ambulatory electrocardiographic monitoring and blood tests. Regression analysis
was used to evaluate associations between ﬁne particulate matter [aerodynamic diameter ≤ 2.5 µm
(PM2.5)] and HRV, C-reactive protein (CRP), blood cell counts, and whole blood viscosity. A 
100-µg/m3 increase in PM2.5 was associated with approximately a 35 (SE = 8)-msec decline in stan-
dard deviation of all normal R-R intervals (SDNN, a measure of overall HRV); a 42 (SE = 11)-msec
decline in square root of the mean of the squared differences between adjacent normal R-R intervals
(r-MSSD, an estimate of short-term components of HRV); and a 0.81 (SE = 0.17)-mg/dL increase in
CRP. The PM2.5–HRV associations were reasonably consistent and statistically robust, but the CRP
association dropped to 0.19 (SE = 0.10) after excluding the most inﬂuential subject. PM2.5 was not
signiﬁcantly associated with white or red blood cell counts, platelets, or whole-blood viscosity. Most
short-term variability in temporal deviations of HRV and CRP was not explained by PM2.5; how-
ever, the small statistically signiﬁcant associations that were observed suggest that exposure to PM2.5
may be one of multiple factors that inﬂuence HRV and CRP. Key words: cardiovascular disease, 
C-reactive protein, ECG monitoring, heart rate variability, inﬂammation, particulate air pollution,
PM2.5. Environ Health Perspect 112:339–345 (2004). doi:10.1289/ehp.6588 available via
http://dx.doi.org/ [Online 12 November 2003]Subjects were retired persons between 54 and
89 years of age, and 57% were female. All
subjects lived in private homes or were resi-
dents of a retirement home without special air
ﬁltration systems and had no serious medical
conditions that would preclude their partici-
pation. Medical conditions that precluded
participation included diabetes, renal failure,
Parkinson’s disease, mental illness, chronic
alcohol abuse, treatment with oxygen therapy,
abnormal heart rhythm, pacemaker use,
implanted defibrillator use, heart transplant,
or heart failure within the previous 6 months.
Research protocols and consent forms were
approved by the institutional review board
for human subjects at Brigham Young
University. Before entering the study, all par-
ticipants read and signed consent forms and
completed a questionnaire pertaining to back-
ground information, medical history, and
prescription medications. Subjects received
$100 for participating in the study.
The speciﬁc days of health data collection
for each panel along with PM2.5 concentra-
tions are presented in Figure 1. Multiple obser-
vations on the subjects were collected over the
study periods. The days that health end point
data were collected were not random because
of the effort to collect health data for each sub-
ject at least once during periods of relatively
high pollution and at least once during periods
of relatively low pollution.
Pollution and weather data. Daily data
for temperature and relative humidity were
obtained for the Salt Lake City, Utah,
International Airport monitoring station
from the National Climatic Data Center
(www.ncdc.noaa.gov). In addition, the
National Weather Service computes an air
stagnation index for the Wasatch Front. This
index, also called the clearing index, is a proﬁle
of the atmosphere that incorporates tempera-
ture, moisture, and winds into an index that
measures the vertical and horizontal motion of
particles in the air (Jackman and Chapman
1977). The clearing index ranges from 0 to
1,050, where the values indicate the relative air
stagnation. As climatic conditions lead to
more stagnant air, the clearing index falls, and
as conditions lead to less stagnant air, the
clearing index rises, usually quite rapidly.
Daily 24-hr monitoring of airborne
PM2.5 was conducted by the State of Utah
Division of Air Quality according to the U.S.
Environmental Protection Agency’s (U.S. EPA)
federal reference method (FRM; U.S. EPA
1997). Nonvolatile, PM2.5 mass concentrations
were determined using tapered element
oscillating microbalance (TEOM) monitors
(Patashnick and Rupprecht 1991). Total PM2.5
mass, including semivolatile mass (SVM), was
measured using two sampling methods. The
ﬁrst was a real-time total ambient mass sampler
(RAMS), based on diffusion denuder, Naﬁon
(Perma Pure LLC, Toms River, NJ) dryer, and
TEOM monitor technology. This sampler has
been described in detail elsewhere (Eatough
et al. 1999, 2001). The second method used
the Particle Concentrator-Brigham Young
University Organic Sampling System (PC-
BOSS) to measure ﬁne particulate mass, crustal
and trace elements, sulfate, carbonaceous mate-
rial (elemental and organic), nitrate, semi-
volatile organic compounds, and semivolatile
nitrate. The conﬁguration and operation of the
PC-BOSS as used in this study have been previ-
ously described in detail (Lewtas et al. 2001).
These monitors were co-located with the State
of Utah Division of Air Quality Hawthorne,
Bountiful, and Lindon monitoring stations.
Because of the inability to predict pollution
episodes more than a few days in advance and
because of the complexity and experimental
nature of some of the pollution monitoring, var-
ious scheduling and equipment failures meant
that some pollution data were missing during
blocks of time when health data were being col-
lected. The most consistently reliable data were
the PM2.5 FRM data. However, even these data
had some days missing. These missing data
were estimated and ﬁlled in by extrapolation of
the available data from the neighboring days
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Figure 1. PM2.5 concentrations and number of observations of health end points for (A) Hawthorne winter,
(B) Hawthorne summer, (C) Bountiful, and (D) Lindon. Black dots represent PM2.5 data collected by the State
of Utah Division of Air Quality according to the U.S. EPA’s FRM. Green dots represent missing data that
were estimated using neighboring days and the clearing index. Bars represent the number of observations
of health end points collected on given days. Black, red, green, yellow, and blue bars represent the ﬁrst,
second, third, fourth, and ﬁfth time period of health data collection, respectively.
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Hawthorne winter (1999/2000)
Hawthorne summer (2000)
Bountiful (2000/2001)
Lindon (2000/2001)if there were no large changes in the clearing
index, or by projection of data consistent with
observed changes in the clearing index. As
reported elsewhere (Eatough et al. 2003), the
RAMS and PC-BOSS monitors provided
nearly equivalent estimates of the PM2.5 mass,
including SVM. For this analysis, the averages
of the nonmissing values from 24-hr concen-
trations calculated from RAMS and PC-BOSS
were used as estimates of total ﬁne particulate
mass. Figure 1 illustrates the PM2.5 concentra-
tions using FRM-filled data and the time of
health data collection for each panel. Figure 2
presents PM2.5 measurements from FRM-
filled, TEOM, and RAMS/PC-BOSS moni-
tors plotted with the clearing index.
Ambulatory ECG monitoring. Repeated 
24-hr ambulatory ECG monitoring was con-
ducted on the subjects during periods of
both low and high air pollution. Participants
were hooked up to the monitors by a trained
technician in their homes. The hookup of a
modified V5 and VF bipolar lead placement
were used, and skin preparation, electrode
placement, and related protocols were similar to
those described elsewhere (Marquette Medical
Systems 1996). ECGs were recorded digitally
(sampling rate, 256 Hz/channel) on removable
flash cards using a lightweight, two-channel,
ambulatory ECG monitor (Trillium3000;
Forest Medical, East Syracuse, NY). The ECG
digital recordings were processed, and mean
heart rate and various measures of HRV were
calculated for each 24-hr session using PC-
based software (Trillium3000 PC Companion
Software for MS Windows; Forest Medical).
Three measures of HRV were calculated and
used in this analysis: a) SDNN, the standard
deviation of all normal R-R (or NN) intervals
during the 24-hr period; b) SDANN, the stan-
dard deviation of the average NN intervals in
all 5-min segments of the 24-hr period; and
c) r-MSSD, the square root of the mean of
the squared differences between adjacent
NN intervals. SDNN is an estimate of overall
HRV, SDANN reflects variability due to
cycles longer than 5 min and is an estimate of
long-term components of HRV, and r-MSSD
reﬂects high-frequency variations and is an esti-
mate of short-term components of HRV. A
detailed discussion of the physiologic interpre-
tation of these measures is presented elsewhere
(Task Force 1996).
Blood collection and analysis. Immediately
after each 24-hr ECG monitoring period,
blood was drawn using standardized proce-
dures for venipuncture, collection, storage,
and shipment. Blood cell counts and differen-
tial white cell counts were determined using
an automated cell counter with ﬂow differen-
tial (Advia 120 hematology system; Bayer
Corporation, Leverkusen, Germany); C-reac-
tive protein (CRP) was measured using neph-
elometry (IMMAGE Immunochemistry
Systems, CRP Kit 447280; Beckman Coulter
Instruments, Brea, CA); whole blood viscosity
was measured using a cone-plate viscometer
(model DZ-2+; Brookfield Engineering
Laboratories Inc., Middleboro, MA). All of
the blood tests were conducted at ARUP
Laboratories in Salt Lake City.
Analytic methods. As illustrated in Figure 1,
we attempted to collect health data during
times of both high and low PM2.5 concentra-
tions. Associations for each of the heart rate,
HRV, and blood measures were evaluated sta-
tistically using various regression models. To
account for subject-specific differences two
approaches were used: a) Deviations from each
individual subject’s mean were calculated and
used as the dependent variables in the regres-
sion models, and b) subject-speciﬁc ﬁxed effects
(Greene 2000) were included in the regression
models. Three approaches were used to control
for weather variables: a) Both linear and qua-
dratic terms for daily average temperature and
relative humidity were included in the models,
b) additive cubic smoothing splines with 3
degrees of freedom (df) for average temperature
and relative humidity were included in the
models, and c) cubic smoothing splines with a
functional two-way interaction between average
temperature and relative humidity using 6 df
were included in the models. Mean heart rate
was included in some of the models for SDNN,
SDANN, and r-MSSD. Although most of the
models included PM2.5 as a linear term, models
that included cubic smoothing splines with 3 df
for PM2.5 were also estimated. The statistical
analysis was conducted using SAS statistical
software (SAS Institute 2001) estimating the
fully parametric regression models using PROC
REG and estimating the regression models that
included cubic smoothing splines using the
“spline” and “spline2” functions in the model
statement of PROC GAM.
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Figure 2. PM2.5 measurements for (A) Hawthorne winter, (B) Hawthorne summer, (C) Bountiful, and (D)
Lindon; from FRM-ﬁlled (thick black lines), RAMS/PC-BOSS (red), and TEOM (blue) monitors plotted with
the clearing index (thin black lines).
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estimated regression models by labeling resid-
uals and partial residuals by subject number
and plotting them over pollution levels. We
then evaluated the sensitivity of the results to
influential subjects by estimating the regres-
sion models with the influential subjects
excluded. Also, we estimated models for dif-
ferent lagged days of exposure and for PM2.5
concentrations measured by the alternative
monitoring approaches.
Results
Summary statistics for the pollution, weather,
and health variables are presented in Table 1.
As Table 1 and Figure 1 show, during the
study period PM2.5 pollution levels rarely
exceeded the U.S. National Ambient Air
Quality 24-hr standard of 65 µg/m3 (U.S. EPA
1996, 1997). The mean levels of the HRV and
blood measures were not remarkable.
Table 2 presents the regression coefﬁcients
for ﬁve alternative regression models. Elevated
concentrations of PM2.5 were consistently asso-
ciated with declines in all three measures of
HRV, SDNN, SDANN, and r-MSSD. As
expected, there were substantial cross-subject
differences in these HRV measures. There were
also statistically signiﬁcant associations between
HRV and temperature and relative humidity.
However, the associations between HRV and
these weather variables were nonlinear and
likely interactive. For example, model V
included a cubic smoothing spline that allowed
for both nonlinearity and two-way interactions
with temperature and relative humidity. The
chi-squared test for this smoothing spline indi-
cated a statistically signiﬁcant ﬁt (p < 0.05) for
SDNN and r-MSSD. Nevertheless, negative
associations between PM2.5 and HRV were
clearly observed even when accounting for
subject-specific differences and controlling
for temperature and relative humidity using
various modeling approaches.
Elevated concentrations of PM2.5 were
associated with increases in CRP and mono-
cytes. As with the HRV measures, these asso-
ciations were not highly sensitive to the
various modeling approaches presented in
Table 2. PM2.5 was not significantly associ-
ated with whole-blood viscosity, other white
blood cell counts, red blood cells, or platelets.
Figure 3 presents partial residuals (after
controlling differences in individual means and
for temperature and relative humidity) from
model I for SDNN and CRP. For conve-
nience, the residuals in Figure 3 are labeled
by subject number and plotted over PM2.5.
Similar partial residual plots are obtainable
using the other four modeling approaches. Full
residual plots for all of the end points were also
created and analyzed. As was observed in the
residual plots and as shown in Figure 3, some
subjects provided highly influential observa-
tions. For CRP, one subject (subject 15) was
clearly highly inﬂuential. A single inﬂuential
subject was also observed for mean heart rate
and monocytes (subjects 77 and 5, respectively;
Article | Pope et al.
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Table 1. Summary statistics of key variables used in analysis.
Variable Unit Reference rangea No. Mean ± SD Min–Max
PM2.5 (FRM-Filled) µg/m3 — 250 23.7 ± 20.2 1.7–74.0
PM2.5 (not ﬁlled) µg/m3 — 182 25.8 ± 21.2 1.7–74.0
PM2.5 (TEOM) µg/m3 — 223 18.9 ± 13.4 2.2–61.5
PM2.5 (RAMS/PC-BOSS) µg/m3 — 236 26.5 ± 18.8 5.6–72.4
Average temperature °F — 250 43.3 ± 20.8 19.0–87.0
Average relative humidity % — 250 67.5 ± 18.9 24.5–92.0
Mean heart rate bpm — 247 72.1 ± 9.8 50–104
SDNN msec — 246 131.4 ± 43.1 45–317
SDANN msec — 246 109.0 ± 38.1 37–376
r-MSSD msec — 246 69.7 ± 59.5 14–323
CRP mg/dL 0.0–0.8 244 0.50 ± 0.60 0.10–7.8
Whole blood viscosity cP 3.6–6.0 248 5.15 ± 0.76 0.80–8.3
White blood cells k/µL 3.2–10.6 250 6.99 ± 1.59 3.60–14.11
Granulocytes k/µL 1.3–7.0 237 4.26 ± 1.20 2.10–11.10
Lymphocytes k/µL 0.8–3.1 237 2.14 ± 0.72 0.50–4.60
Monocytes k/µL 0.1–0.5 237 0.41 ± 0.16 0.10–1.30
Basophils k/µL 0.0–0.1 237 0.05 ± 0.05 0.00–0.20
Eosinophils k/µL 0.0–0.4 237 0.19 ± 0.11 0.00–0.70
Red blood cells M/µL 4.69–6.07 250 4.75 ± 0.43 3.32–6.16
Platelets k/µL 177–406 250 249.3 ± 58.7 101.0–457.0
Abbreviations; bpm, beats per minute; cP, centipoise; k/µL, thousands per microliter; Max, maximum; Min, minimum;
M/µL, millions per microliter.
aInterpretive normal reference ranges for blood parameters assessed by ARUP Laboratories.
Table 2. PM2.5 regression coefﬁcients [×100 (SEs)] for various regression models using all subjects and FRM-ﬁlled PM2.5 data.
Model parameters I II III IV V
Control for Dependent Subject-speciﬁc Subject-speciﬁc Subject-speciﬁc Subject-speciﬁc
cross-subject variables are ﬁxed effects ﬁxed effects ﬁxed effects ﬁxed effects
differences deviations from
individual means
Control for Quadratic Quadratic Additive spline Additive spline Interactive spline
other factors functionsa for functionsa for smooths for smooths for smooths for temp,
temp, RH temp, RH temp, RHb temp, RHb plus RH; partial
control for HRc control for HRd
Mean heart rate –3.83 (2.5) –5.23 (3.47) –5.14 (2.42)** — –4.49 (1.73)**
SDNN –31.45 (12.27)** –37.76 (17.01)** –34.36 (12.13)# –41.71 (11.67)# –34.94 (8.32)#
SDANN –16.80 (12.55) –19.92 (17.46) –17.42 (12.43) –22.93 (12.20)* –18.98 (8.67)**
r-MSSD –39.31 (15.64)** –50.59 (21.60)** –45.82 (15.42)# –51.15 (15.27)# –42.25 (10.90)#
CRP 0.78 (0.25)# 0.95 (0.35)# 0.96 (0.25)# — 0.81 (0.18)#
Whole blood viscosity 0.10 (0.30) 0.12 (0.42) –0.00 (0.30) — 0.07 (0.21)
White blood cells 0.15 (0.55) 0.25 (0.75) 0.21 (0.53) — –0.07 (0.38)
Granulocytes 0.21 (0.53) 0.38 (0.72) 0.33 (0.51) — 0.02 (0.37)
Lymphocytes –0.06 (0.20) –0.09 (0.28) –0.06 (0.20) — –0.07 (0.14)
Monocytes 0.13 (0.06)** 0.15 (0.08)** 0.14 (0.05)** — 0.12 (0.04)#
Basophils –0.02 (0.02) –0.02 (0.03) –0.01 (0.02) — –0.01 (0.01)
Eosinophils –0.03 (0.03) –0.03 (0.04) –0.02 (0.03) — –0.01 (0.02)
Red blood cells 0.04 (0.09) 0.03 (0.13) 0.00 (0.09) — 0.03 (0.06)
Platelets 0.58 (13.33) –1.18 (18.49) 2.29 (13.14) — 0.31 (9.34)
Abbreviations; RH, relative humidity; temp, temperature.
aIncludes linear and quadratic terms for average temperature and relative humidity. bIncludes cubic smoothing splines with 3 df for average temperature and relative humidity. cIncludes
24-hr mean heart rate. dIncludes a cubic smoothing spline with a functional two-way interaction between average temperature and relative humidity using 6 df. Models for SDNN,
SDANN, and r-MSSD also includes mean heart rate. *p ≤ 0.10; **p ≤ 0.05; #p ≤ 0.01.residual plots not shown). For the three meas-
ures of HRV (only SDNN shown in Figure 3),
two subjects (89 and 66) appeared to be most
inﬂuential, with two other subjects (36 and 77)
successively less so. For the other end points,
no influential subjects were clearly observed.
Table 3 presents the PM2.5 regression coefﬁ-
cients using model V excluding various num-
bers of inﬂuential subjects. For the measures of
HRV, excluding inﬂuential subjects produced
somewhat smaller estimated PM2.5 effects, but
the effects remained negative and generally sta-
tistically significant. For CRP, excluding the
single highly influential subject produced a
substantially smaller estimated PM2.5 effect
that was marginally signiﬁcant (p = 0.06). For
mean heart rate and monocytes, excluding the
influential subjects resulted in reduced and
statistically insigniﬁcant associations with PM2.5.
As illustrated for SDNN and CRP in
Figure 3, associations with PM2.5 were nearly
linear. Goodness-of-ﬁt tests, based on models
that included cubic smoothing splines with
3d f   for PM2.5, indicated that PM2.5 associa-
tions with r-MSSD but not SDNN, SDANN,
or CRP were signiﬁcantly different from linear
(p < 0.05). However, after inﬂuential observa-
tions were removed, no associations between
PM2.5 and SDNN, SDANN, r-MSSD, or
CRP were significantly different from linear
(p > 0.25).
Table 4 presents regression coefficients
with model V using different lagged days of
exposure. The strongest associations between
PM2.5 and HRV were with concurrent-day
exposures with effect estimates generally
decreasing for longer exposure lag times. For
CRP, the concurrent-day exposures were also
most strongly associated with CRP, but a
relatively large effect was also observed for the
3 days’ previous exposure.
As shown in Figures 1 and 2, for all meas-
ures of PM2.5 during prolonged periods with a
very low and stable clearing index (indicating
very stagnant air conditions), PM2.5 concentra-
tions tended to rise and then drop rapidly with
the eventual and inevitable rapid rise in the
clearing index. Using model V, measures of
HRV and CRP were also regressed on other
estimates of concentrations of PM2.5, including
FRM without filling in missing values and
the TEOM and RAMS/PC-BOSS measures
(results not shown). For the FRM (not ﬁlled)
and for TEOM, PM2.5 effect estimates were
nearly identical to those reported in Table 2.
For the PM2.5 concentrations measured using
RAMS/PC-BOSS that included SVM, the
results were similar for CRP, but statistically
significant negative associations were not
observed for measures of HRV. However,
there were 10 days with abnormally high levels
of SVM (> 15 µg/m3), caused by abnormally
elevated concentrations of ammonium nitrate.
When these 10 days were deleted from the
analysis, statistically signiﬁcant negative associ-
ations, similar to those presented in Table 2,
were observed for PM2.5 from the RAMS/
PC-BOSS monitors.
Discussion
In this study we hypothesized that altered
cardiac autonomic function, as indicated by
changes in measures of HRV, and pulmonary
inflammation, as measured by various blood
markers of inﬂammation, would be associated
with ambient concentrations of PM2.5.
Reasonably consistent and statistically robust
negative associations between PM2.5 and meas-
ures of HRV were observed. PM2.5 was signiﬁ-
cantly associated with CRP but not with
changes in white blood cell counts, red blood
cells, platelets, or whole-blood viscosity. The
PM2.5 associations with CRP are interesting
and suggestive, but given that they depend
largely on a highly inﬂuential subject, they are
not compelling.
Previous studies have reported HRV asso-
ciations with ambient PM air pollution expo-
sure (Gold et al. 2000; Liao et al. 1999; Pope
et al. 1999), occupational PM exposure
(Magari et al. 2001), and PM exposure from
secondhand cigarette smoking in an airport
smoking lounge (Pope et al. 2001). A previ-
ous study that used 24-hr ambulatory ECG
monitoring was also conducted along the
Wasatch Front in Utah (Pope et al. 1999), but
it had only seven participants with a total of
39 observations and had air pollution monitor-
ing only for PM ≤ 10 µm in aerodynamic
diameter (PM10). This study estimated that a
100-µg/m3 increase in PM10 was associated
with an 18-msec decrease in 24-hr SDNN.
Assuming a PM2.5:PM10 ratio of 0.60, this
would suggest a 30-msec decline in 24-hr
SDNN associated with a 100-µg/m3 increase in
PM2.5—an estimate remarkably close to that
observed in this study. However, unlike in the
present analysis, PM pollution was associated
with increases in 24-hr r-MSSD. Another study
conducted in Boston, Massachusetts, estimated
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Figure 3. Partial residuals (after controlling for
subject-speciﬁc differences, temperature, and rela-
tive humidity) from model I for (A) SDNN and (B)
CRP plotted over PM2.5. Residuals are labeled by
subject number.
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Table 3. PM2.5 (FRM-ﬁlled) regression coefﬁcients [×100 (SEs)] using model Va, excluding various numbers
of inﬂuential subjects.
Excluding two Excluding three Excluding four
Excluding most most inﬂuential most inﬂuential most inﬂuential
inﬂuential subjectb subjectsb subjectsb subjectsb
Mean heart rate –1.66 (1.55) — — —
SDNN — –23.70 (7.13)# –31.01 (6.75)# –26.39 (6.84)#
SDANN — –14.37 (6.96)** –23.09 (6.31)# –19.94 (6.41)#
r-MSSD — –25.63 (8.95)# –34.96 (8.45)# –21.77 (7.96)#
CRP 0.19 (0.10)* — — —
Monocytes 0.02 (0.03) — — —
aThis model included subject-specific fixed effects and cubic smoothing splines with a functional two-way interaction
between average temperature and relative humidity using 6 df. Models for SDNN, SDANN, and r-MSSD also included
mean heart rate. bThese models excluded highly inﬂuential subjects as determined by residual analysis. Only one subject
was excluded for mean heart rate (subject 77), CRP (15), and monocytes (5). For the HRV measures, SDNN, SDANN, and 
r-MSSD, initially two subjects were excluded (66 and 89), then three (36, 66, 89), and then four (36, 66, 89, 77). *p ≤ 0.10;
**p ≤ 0.05; #p ≤ 0.01.
Table 4. PM2.5 (FRM-ﬁlled) regression coefﬁcients [×100 (SEs)] using model Va using different lagged days
of pollution exposure.
Concurrent day Previous day Two days previous Three days previous
SDNN –34.94 (8.32)# –19.37 (9.21)** –17.03 (9.62)* –10.22 (10.12)
SDANN –18.98 (8.67)** –10.22 (9.51) –6.80 (9.94) –1.52 (10.43)
r-MSSD –42.25 (10.90)# –26.27 (12.02)** –27.66 (12.54)** –20.77 (13.20)
CRP 0.81 (0.18)# 0.33 (0.20)* 0.38 (0.20)* 0.64 (0.21)#
aThis model included subject-specific fixed effects and cubic smoothing splines with a functional two-way interaction
between average temperature and relative humidity using 6 df. Models for SDNN, SDANN, and r-MSSD also included
mean heart rate. *p ≤ 0.10; **p ≤ 0.05; #p ≤ 0.01.the effect of average PM2.5 levels over the pre-
vious 4 hr on SDNN and r-MSSD during a
25-min period of alternating rest and exercise
in a panel of 21 participants 53–87 years of age
with a total of 163 monitoring sessions (Gold
et al. 2000). A 100-µg/m3 increase in exposure
to PM2.5 was associated with an approximately
24-msec decline in both SDNN and r-MSSD.
The physiologic importance of these
observed changes in HRV is not fully under-
stood, yet there is growing recognition of the
role of autonomic dysfunction in cardiovascu-
lar mortality, and HRV measures provide
quantitative, well-deﬁned indicators of cardiac
autonomic function (Task Force 1996). For
example, decreases in HRV are strong predic-
tors of mortality (Kennedy 1997; La Rovere
et al. 2003), and autonomic nervous system–
activated changes in HRV may increase the
likelihood of sudden cardiac death (Task Force
1996). In addition, decreased 24-hr SDNN
has been associated with all-cause mortality
and has been found to be a signiﬁcant predic-
tor of death due to progressive heart failure in
patients with chronic heart failure (Nolan et al.
1998). In a panel of 433 participants with a
mean age of 62 years, a 41.2-msec decrease in
SDNN from the mean SDNN of study par-
ticipants (113.4) was associated with a relative
risk of 1.62 for all-cause mortality and a rela-
tive risk of 2.45 for progressive heart failure.
In our present analysis, similar declines in
SDNN were associated with an increase in
exposure of approximately 100 µg/m3 PM2.5,
but it is unknown how these acute declines in
HRV may reflect increased risk for adverse
cardiovascular events.
The suggested associations between PM2.5
and CRP are intriguing. The MONICA-
Augsburg study also reported evidence of
increased CRP associated with PM air pollu-
tion (Peters et al. 2001). A 3-fold increase in
the odds of having CRP > 5.7 mg/L was asso-
ciated with a marked pollution episode. Using
multivariate regression analysis, the study also
found an increase in CRP of 0.88 mg/L asso-
ciated with an increase of 26 µg/m3 in the
previous 5-day average concentration of total
suspended particles, which converts to a CRP
increase of 0.34 mg/dL for a 100-µg/m3
increase in the 5-day average total suspended
particles. This estimated change is roughly
comparable with changes observed in the
present analysis. Seaton et al. (1999) also
reported a positive association between PM10
and CRP. A 147% (95% conﬁdence interval,
20–477) increase in CRP was associated with
a 100-µg/m3 increase in PM10.
Recently, much attention has been placed
on CRP as an indicator of acute phase response
and as a risk factor for cardiovascular events.
Remarkably small changes in CRP have been
associated with changes in cardiac risk.
In a study by Ridker et al. (2002) involving
approximately 28,000 American women, the
relative risk of a first cardiovascular event
increased with higher quintiles of CRP. The
CRP range for the fourth quintile reported by
Ridker et al. (2002) was 2.09–4.19 mg/L. The
median CRP in our present study (0.4 mg/dL
or 4 mg/L), therefore, would fall within the
upper range of this fourth quintile. Also, the
estimated increase in CRP associated with a
100-µg/m3 increase in PM2.5 reported in this
study, even excluding the highly influential
observation (0.19 mg/dL or 1.9 mgL), was
approximately equal to or greater than the
range of the CRP quintiles reported by Ridker
et al. (2002). However, it is uncertain how
these acute changes in CRP effect or reflect
potential changes in cardiovascular risk.
The analysis using the RAMS/PC-BOSS
data observed that the PM–HRV associations
were much smaller on days with high SVM,
especially if the SVM was rich in nitrate.
These results are not well understood, but
they imply that nitrate may have a smaller
impact than do other fine particles or that
nitrate exposure is not well accounted for
by central-site monitoring (Patterson and
Eatough 2000). The health associations for
PM2.5 measured by TEOM (which includes
no SVM), PM2.5 measured by FRM (which
includes some SVM), and PM2.5 measured by
RAMS/PC-BOSS (which is designed to meas-
ure total PM including SVM) after deleting
days with abnormally high levels of ammo-
nium nitrate were all similar. These results
suggest that organic semivolatiles may have
effects similar to those of the nonvolatile PM
and point toward the need for further particle
characterization in health studies of PM pollu-
tion. Additional study with other pollution
measures including gaseous pollutants may be
important.
Although in this study we observed statis-
tical associations between PM2.5 and HRV
and CRP, most of the relevant variability in
the temporal deviations of these physiologic
end points was not explained by PM2.5. The
fact that small but statistically signiﬁcant asso-
ciations were observed suggests that PM2.5
may be one of multiple factors that inﬂuence
HRV and CRP. These results suggest that
altered cardiac autonomic function and pul-
monary/systemic inflammation may play a
role in pathogenesis relating to the harmful
effects of PM air pollution on human health.
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